Drug testing and antibioticsEdexcel A-Level Biology A: Flashcards
What these 14 flashcards ask
- Who tested digitalis (foxglove) on patients in 1785?
- Name two weaknesses of Withering's trial.
- What is a placebo?
- What does double blind mean?
- Why are patients allocated at random in a trial?
- What is tested in phase 1?
- What is tested in phase 2?
- What is tested in phase 3?
- What nutrients do bacteria need to grow in culture?
- Why is a school incubator kept at 25 °C or lower?
- Why is the culture dish taped with two pieces of tape?
- What is a zone of inhibition?
- How do you calculate the area of a clear zone?
- What are the controls in the antimicrobial plant practical?
Exam questions on Drug testing and antibiotics
- In 1785 the doctor William Withering published an account of treating patients who had dropsy (swelling caused by fluid retention) with a herbal remedy later known as digitalis soup. By testing the plants in the mixture separately he showed that foxglove was the active ingredient, and he adjusted the dose according to the response of more than 100 of his patients. He recorded the doses and the outcomes, but all of the patients knew they were being given the remedy.Explain why modern drug trials are double blind.2 marks
- A pharmaceutical company has developed a new drug to lower blood pressure. After testing on cells and animals, it must pass three phases of clinical trials before it can be licensed for use.Suggest why phase 1 uses healthy volunteers rather than patients with high blood pressure.2 marks
- A student cultures bacteria on nutrient agar in a school laboratory to find out how well the bacteria grow. The student must give the bacteria the conditions they need and must not allow microorganisms from the environment to get into the plates.Explain three conditions that the student must provide to allow the bacteria to grow on the agar.3 marks
Written by the Exaim team, led by Shaun Daswani (Head of Upper Secondary, Improve ME Institute; MSc Financial Mathematics, Imperial College London; BSc, UCL) and Jason Daswani (operational lead, Improve ME Institute; LSE).